CX Institutional’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$724K Buy
8,557
+1,455
+20% +$117K 0.02% 384
2026
Q1
$502K Sell
7,102
-102,378
-94% -$7.66M 0.02% 458
2025
Q4
$8.64M Buy
109,480
+13,508
+14% +$1.07M 0.26% 97
2025
Q3
$7.91M Buy
95,972
+22,285
+30% +$1.75M 0.24% 104
2025
Q2
$5.93M Buy
73,687
+628
+0.9% +$48.5K 0.21% 123
2025
Q1
$5.87M Buy
73,059
+5,054
+7% +$420K 0.22% 103
2024
Q4
$5.57M Buy
68,005
+9,337
+16% +$777K 0.22% 110
2024
Q3
$4.84M Buy
58,668
+51,370
+704% +$3.84M 0.21% 130
2024
Q2
$512K Buy
7,298
+1,673
+30% +$119K 0.02% 368
2024
Q1
$417K Buy
5,625
+229
+4% +$16K 0.02% 388
2023
Q4
$357K Buy
5,396
+10
+0.2% +$626 0.02% 369
2023
Q3
$339K Buy
5,386
+577
+12% +$35.9K 0.02% 380
2023
Q2
$272K Buy
+4,809
New +$267K 0.01% 450
2023
Q1
Sell
-4,366
Closed -$316K 541
2022
Q4
$316K Buy
+4,366
New +$313K 0.02% 424
2022
Q3
Sell
-2,872
Closed -$180K 873
2022
Q2
$180K Buy
+2,872
New +$190K 0.01% 453
2021
Q4
Sell
-1,926
Closed -$119K 695
2021
Q3
$119K Buy
1,926
+387
+25% +$23.3K 0.01% 420
2021
Q2
$92K Buy
1,539
+142
+10% +$9K 0.01% 448
2021
Q1
$85K Buy
1,397
+116
+9% +$6.4K 0.01% 402
2020
Q4
$60K Buy
1,281
+726
+131% +$31.5K 0.01% 419
2020
Q3
$21K Buy
555
+122
+28% +$4.63K ﹤0.01% 536
2020
Q2
$16K Sell
433
-93
-18% -$3.24K ﹤0.01% 488
2020
Q1
$16K Buy
526
+28
+6% +$1.24K ﹤0.01% 405
2019
Q4
$25K Buy
498
+45
+10% +$2.17K ﹤0.01% 327
2019
Q3
$21K Sell
453
-443
-49% -$21.1K ﹤0.01% 368
2019
Q2
$45K Sell
896
-42,176
-98% -$1.98M 0.01% 325
2019
Q1
$1.83M Buy
43,072
+42,946
+34,084% +$1.9M 0.32% 93
2018
Q4
$5K Hold
126
﹤0.01% 395
2018
Q3
$6K Hold
126
﹤0.01% 285
2018
Q2
$5K Buy
+126
New +$5.87K ﹤0.01% 265

Other funds holding MET

CX Institutional's MET Position: Q2 2026 in Review

CX Institutional increased its MetLife (MET) stake by 20% in Q2 2026, buying an estimated $117K and bringing the position to 8,557 shares worth $724K. The position accounts for 0.02% of the portfolio, ranked #384.

CX Institutional first reported a position in MET in Q2 2018 and has held it in 29 quarters since. The position peaked at $8.64M in Q4 2025. 297 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • CX Institutional held 8,557 shares of MetLife worth $724K as of Q2 2026.
  • CX Institutional bought 1,455 MetLife shares in Q2 2026, an estimated $117K.
  • MetLife made up 0.02% of CX Institutional's portfolio in Q2 2026, its #384 holding.
  • CX Institutional first reported a position in MetLife in Q2 2018 and has held it in 29 quarters since.
  • CX Institutional's MetLife position peaked at $8.64M in Q4 2025.
  • 297 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.